Related references
Note: Only part of the references are listed.Prostate cancer dormancy and recurrence
Frank C. Cackowski et al.
CANCER LETTERS (2022)
Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer
Yutaka Iwagoi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Mechanisms, Diagnosis and Treatment of Bone Metastases
Jozef Ban et al.
CELLS (2021)
Leptin and Obesity: Role and Clinical Implication
Milan Obradovic et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
Mara Artibani et al.
JCI INSIGHT (2021)
Bone marrow/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells
M. C. Sanmartin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
The pathogenesis of bone metastasis in solid tumors: a review
Ivan Vicic et al.
CROATIAN MEDICAL JOURNAL (2021)
Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism
Samrita Dogra et al.
MOLECULAR CANCER RESEARCH (2021)
Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass
Matthew F. Buas et al.
SCIENTIFIC REPORTS (2021)
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunothrapy
Sonia Iyer et al.
CANCER DISCOVERY (2021)
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis
Chaoyang Sun et al.
ONCOGENE (2020)
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
Chunyan Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance
Abir Mukherjee et al.
CANCER RESEARCH (2020)
IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer
Jirui Wen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway
Jing Zhao et al.
CELL DEATH & DISEASE (2020)
Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms
Tsai-Tsen Liao et al.
CELLS (2020)
Effect of circulating exosomes derived from normal-weight and obese women on gluconeogenesis, glycogenesis, lipogenesis and secretion of FGF21 and fetuin A in HepG2 cells
Reza Afrisham et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Single-cell EMT-related transcriptional analysis revealed intra-cluster heterogeneity of tumor cell clusters in epithelial ovarian cancer ascites
Tongtong Kan et al.
ONCOGENE (2020)
Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
Yanfei Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Kimberly R. Jordan et al.
CLINICAL CANCER RESEARCH (2020)
Identification of Serum Exosomal MicroRNA Expression Profiling in Menopausal Females with Osteoporosis by High-throughput Sequencing
Jian-li Shao et al.
CURRENT MEDICAL SCIENCE (2020)
Metastatic brain disease in early stage ovarian cancer: A case report
Sophia Halassy et al.
GYNECOLOGIC ONCOLOGY REPORTS (2020)
Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC
Bincy John et al.
ONCOGENE (2019)
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
Cornelia Kroger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
Fei Gu et al.
ONCOLOGY LETTERS (2019)
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret et al.
CANCERS (2019)
Enhanced penetration and cytotoxicity of metformin and collagenase conjugated gold nanoparticles in breast cancer spheroids
Elaheh Dalir Abdolahinia et al.
LIFE SCIENCES (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease
Angela Santoro et al.
FRONTIERS IN ONCOLOGY (2019)
Hopes and failures in front-line ovarian cancer therapy
Irina Tsibulak et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Adipocytes promote ovarian cancer chemoresistance
Jiang Yang et al.
SCIENTIFIC REPORTS (2019)
Omentum a powerful biological source in regenerative surgery
Valerio Di Nicola
REGENERATIVE THERAPY (2019)
Nanotechnology advances towards development of targeted-treatment for obesity
Nicole Remaliah Samantha Sibuyi et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
Stefan Enroth et al.
COMMUNICATIONS BIOLOGY (2019)
Secondary debulking for ovarian carcinoma relapse: The R-R dilemma - is the prognosis different for residual or recurrent disease?
John D. Spiliotis et al.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION (2019)
Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways
Ahmad Ghasemi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer
Masakazu Sato et al.
ONCOLOGY LETTERS (2018)
Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated
Martin Zacharias et al.
BMC CANCER (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The latest animal models of ovarian cancer for novel drug discovery
Elizabeth Magnotti et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion
Jessica Tang et al.
MOLECULAR CANCER RESEARCH (2018)
Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression
Jin-Yong He et al.
CELL COMMUNICATION AND SIGNALING (2018)
Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice
Carlos Castano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-beta 1-induced differentiation of human cardiac fibroblasts into myofibroblasts
Tacia Tavares Aquinas Liguori et al.
SCIENTIFIC REPORTS (2018)
Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells
Carlos Cardenas et al.
APOPTOSIS (2017)
Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies
Federica Tomao et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Optimizing treatment in recurrent epithelial ovarian cancer
Giacomo Corrado et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
PARP inhibitors: Clinical utility and possibilities of overcoming resistance
Benjamin G. Bitler et al.
GYNECOLOGIC ONCOLOGY (2017)
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
Marina Rosso et al.
PLOS ONE (2017)
Obesity and the tumor microenvironment
Oakley C. Olson et al.
SCIENCE (2017)
Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes
Janani Kumar et al.
ONCOTARGET (2017)
E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis
Chencheng Dai et al.
ONCOTARGET (2017)
Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
Boyun Kim et al.
CANCER RESEARCH AND TREATMENT (2017)
Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy
Reeta Kangas et al.
SCIENTIFIC REPORTS (2017)
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Xiaoguang Tong et al.
MOLECULAR ONCOLOGY (2016)
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche
Fabrizio Miranda et al.
CANCER CELL (2016)
Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study
Cecilie L. Bager et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Redefining the origin and evolution of ovarian cancer: a hormonal connection
Carlos Cardenas et al.
ENDOCRINE-RELATED CANCER (2016)
Targeting the tumour microenvironment in ovarian cancer
Jean M. Hansen et al.
EUROPEAN JOURNAL OF CANCER (2016)
Cell biology of fat storage
Paul Cohen et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
17-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway
Marta Hoffmann et al.
REPRODUCTIVE SCIENCES (2016)
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
Chi Lam Au Yeung et al.
NATURE COMMUNICATIONS (2016)
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
Joao Incio et al.
CANCER DISCOVERY (2016)
Proteomics of ovarian cancer: functional insights and clinical applications
Mohamed A. Elzek et al.
CANCER AND METASTASIS REVIEWS (2015)
High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
Danielle L. Bourgeois et al.
CANCER CELL INTERNATIONAL (2015)
Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition
Kyeong A. So et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis
Bo Ri Seo et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
Kimberley Kolijn et al.
ONCOTARGET (2015)
Interleukin-8 promotes human ovarian cancer cell migration by epithelial-mesenchymal transition induction in vitro
J. Yin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
Q. Cai et al.
ONCOGENE (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers
Amy L. Strong et al.
BREAST CANCER RESEARCH (2015)
Emerging and Evolving Ovarian Cancer Animal Models
Alexander S. Bobbs et al.
CANCER GROWTH AND METASTASIS (2015)
Direct and indirect effects of leptin on adipocyte metabolism
Ruth B. S. Harris
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The Microenvironment Matters: Estrogen Deficiency Fuels Cancer Bone Metastases
Laura E. Wright et al.
CLINICAL CANCER RESEARCH (2014)
Brain metastasis from ovarian cancer: a systematic review
Shabnam Pakneshan et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B
Ian L. P. Beales et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism
Hiroya Ohta et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Biochemistry of adipose tissue: an endocrine organ
Marisa Coelho et al.
ARCHIVES OF MEDICAL SCIENCE (2013)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
The omentum and omentectomy in epithelial ovarian cancer: A reappraisal Part II - The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer
Alon Ben Arie et al.
GYNECOLOGIC ONCOLOGY (2013)
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways
Chiachen Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Role of Minimally Invasive Surgery in Ovarian Cancer
Farr R. Nezhat et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2013)
Correction: Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells
Man-Tat Lau et al.
PLoS One (2013)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
R. Y-J Huang et al.
CELL DEATH & DISEASE (2013)
The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells
Man-Tat Lau et al.
CANCER LETTERS (2012)
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro
V. D'Esposito et al.
DIABETOLOGIA (2012)
Epithelial mesenchymal transition in ovarian carcinoma
Ben Davidson et al.
FRONTIERS IN ONCOLOGY (2012)
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy
M. Markman
ANNALS OF ONCOLOGY (2011)
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
R. Wendel Naumann et al.
DRUGS (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Adipose Tissue Remodeling as Homeostatic Inflammation
Michiko Itoh et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents
Bodil Bjorndal et al.
JOURNAL OF OBESITY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Hepatocyte Growth Factor Induces Invasion and Migration of Ovarian Cancer Cells by Decreasing the Expression of E-Cadherin, β-Catenin, and Caveolin-1
Jun Hu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
Peritoneal Adipocytes and Their Role in Inflammation during Peritoneal Dialysis
Kar Neng Lai et al.
MEDIATORS OF INFLAMMATION (2010)
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
I. Stuart Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas
M. Colomiere et al.
BRITISH JOURNAL OF CANCER (2009)
Development and Validation of a Protein-based Signature for the Detection of Ovarian Cancer
Kyongjin Kim et al.
CLINICS IN LABORATORY MEDICINE (2009)
p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells
Yuen L. Pon et al.
CANCER RESEARCH (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
Apoptosome: a platform for the activation of initiator caspases
Q. Bao et al.
CELL DEATH AND DIFFERENTIATION (2007)
Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity
Lauren N. Bell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Tumor necrosis factor-α differentially modulates CD44 expression in ovarian cancer cells
Neelakandan Muthukumaran et al.
MOLECULAR CANCER RESEARCH (2006)
Diagnosis and management of epithelial ovarian cancer
Snehal Bhoola et al.
OBSTETRICS AND GYNECOLOGY (2006)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The weight of leptin in immunity
A La Cava et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
C Faleiro-Rodrigues et al.
ANNALS OF ONCOLOGY (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44
S Mine et al.
EXPERIMENTAL CELL RESEARCH (2003)
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
CA Sherman-Baust et al.
CANCER CELL (2003)
Composition of the extracellular matrix of the peritoneum
CA Witz et al.
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2001)
Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro
JM Bruun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Adipose tissue as an endocrine organ
RS Ahima et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
